These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29978478)

  • 1. How long does it take until the effects of endoscopic screening on colorectal cancer mortality are fully disclosed?: a Markov model study.
    Chen C; Stock C; Hoffmeister M; Brenner H
    Int J Cancer; 2018 Dec; 143(11):2718-2724. PubMed ID: 29978478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study.
    Brenner H; Kretschmann J; Stock C; Hoffmeister M
    Oncotarget; 2016 Jul; 7(30):48168-48179. PubMed ID: 27340865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.
    Jeon J; Meza R; Hazelton WD; Renehan AG; Luebeck EG
    Cancer Causes Control; 2015 Jun; 26(6):859-70. PubMed ID: 25783458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal age for screening colonoscopy: a modeling study.
    Chen C; Stock C; Hoffmeister M; Brenner H
    Gastrointest Endosc; 2019 May; 89(5):1017-1025.e12. PubMed ID: 30639539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model.
    Heisser T; Hoffmeister M; Brenner H
    Int J Cancer; 2021 Apr; 148(8):1973-1981. PubMed ID: 33320964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: analyses based on 4,407,971 screening colonoscopies.
    Brenner H; Altenhofen L; Stock C; Hoffmeister M
    Eur J Cancer; 2015 Jul; 51(10):1346-53. PubMed ID: 25908273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
    Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
    Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.
    Rodríguez-Moranta F; Trapero-Bertran M; Castells A; Mas-Canal X; Balaguer F; Pellisé M; Gonzalo V; Ocaña T; Trilla A; Piqué JM
    Gastroenterol Hepatol; 2008; 31(7):405-12. PubMed ID: 18783684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.
    Kaminski MF; Bretthauer M; Zauber AG; Kuipers EJ; Adami HO; van Ballegooijen M; Regula J; van Leerdam M; Stefansson T; Påhlman L; Dekker E; Hernán MA; Garborg K; Hoff G
    Endoscopy; 2012 Jul; 44(7):695-702. PubMed ID: 22723185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.
    Zaika V; Prakash MK; Cheng CY; Schlander M; Lang BM; Beerenwinkel N; Sonnenberg A; Krupka N; Misselwitz B; Poleszczuk J
    PLoS One; 2024; 19(5):e0304374. PubMed ID: 38787836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.